Author

Muhammad Zaeem Noman

Luxembourg Institute of HealthORCID 0000-0002-1837-3097Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Akinchan Kumar· 1 shared Andy ChevignéiD· 1 shared Bassam JanjiiD· 1 shared Guy BerchemiD· 1 shared Kris Van Moer· 1 shared Malina XiaoiD· 1 shared Markus W. OllertiD· 1 shared Martyna SzpakowskaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Akinchan Kumar

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyOncoImmunologyPeer-reviewedApr 18, 2025

Targeting the Atypical Chemokine Receptor 2 (ACKR2) improves the benefit of anti-PD-1 immunotherapy in melanoma

Muhammad Zaeem Noman, Martyna Szpakowska, Malina Xiao…·Bassam Janji

This study shows that targeting ACKR2 enhances anti-PD-1 immunotherapy efficacy in melanoma by improving the tumor microenvironment and immune cell infiltration.

3 citations

mousehuman

𝕏 PostBluesky